Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

A global trial finds Wegovy and Ozempic significantly improve liver health in patients and treats those with advanced fatty ...

Malayalam film and television actor Vishnu Prasad passed away at the age of 49 in Kochi while he was undergoing treatment for ...

The Trump administration this April scrapped a Biden-era proposal that would have required state Medicaid programs and allowed federal Medicare to pay for some GLP-1s for obesity treatment. Instead, ...

A new study found that taking a 2.4 mg weekly dose of semaglutide—sold under the brand names Wegovy and Ozempic—for a year and a half reversed fatty liver disease and reduced inflammation in nearly ...

In a new study, Ozempic - a drug sold to help with obesity and diabetes - is attributed to helping this disease.

Of the total ER visits, nearly 70% involved GI issues, 15% of which led to hospitalization, according to a new study.

The phase 3b STEP UP trial in more than 1,400 patients compared a 7.2mg weekly subcutaneous injection of semaglutide to the standard 2.6mg weekly dose sold as Wegovy or a matched placebo.

Novo Nordisk needs the facilities to help ramp up production of key growth medicines, including semaglutide-based Ozempic for diabetes and Wegovy for ... serious chronic diseases," he added.